{"log_id": 6963619000978834324, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 5e-06, "average": 0.99892, "min": 0.988196}, "location": {"width": 766, "top": 191, "height": 39, "left": 275}, "words": "临床研究未证实老年人对该药的反应与年轻人不同,因此,老年患者勿需"}, {"probability": {"variance": 4e-05, "average": 0.997928, "min": 0.964669}, "location": {"width": 812, "top": 240, "height": 36, "left": 229}, "words": "因年龄而调整剂量。如患者伴有严重肝肾功能、心功能减退,用药期间应注意"}, {"probability": {"variance": 1e-06, "average": 0.999342, "min": 0.997573}, "location": {"width": 194, "top": 292, "height": 30, "left": 232}, "words": "观察,可酌情减量"}, {"probability": {"variance": 2e-06, "average": 0.998549, "min": 0.996578}, "location": {"width": 176, "top": 353, "height": 31, "left": 239}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000386, "average": 0.995821, "min": 0.886776}, "location": {"width": 764, "top": 395, "height": 35, "left": 278}, "words": "锂剂与血管紧张素Ⅱ受体拮抗剂及血管紧张素转化酶抑制剂合用,可引起"}, {"probability": {"variance": 0.000237, "average": 0.996108, "min": 0.909617}, "location": {"width": 791, "top": 440, "height": 37, "left": 232}, "words": "可逆性的血锂水平升高和毒性反应,因此锂剂和本品合用须慎重。如需合用"}, {"probability": {"variance": 3.6e-05, "average": 0.994645, "min": 0.979327}, "location": {"width": 291, "top": 490, "height": 35, "left": 232}, "words": "则合用期间应监测血锂水平"}, {"probability": {"variance": 0.000255, "average": 0.995615, "min": 0.910022}, "location": {"width": 764, "top": 533, "height": 37, "left": 280}, "words": "与其他抑制血管紧张素Ⅱ及其作用的药物一样,本品与引起血钾水平升高"}, {"probability": {"variance": 5e-06, "average": 0.998536, "min": 0.989977}, "location": {"width": 811, "top": 582, "height": 31, "left": 233}, "words": "的药物(血管紧张素转化酶抑制剂、保钾利尿药、钾离子补充剂、含钾的盐替"}, {"probability": {"variance": 1.7e-05, "average": 0.998003, "min": 0.975923}, "location": {"width": 809, "top": 626, "height": 35, "left": 233}, "words": "代品、环孢菌素A或其他药物如肝素钠)合用,可致血钾升高,建议监测血钾"}, {"probability": {"variance": 0, "average": 0.999545, "min": 0.999147}, "location": {"width": 51, "top": 677, "height": 29, "left": 233}, "words": "水平"}, {"probability": {"variance": 0.012556, "average": 0.964192, "min": 0.390896}, "location": {"width": 764, "top": 718, "height": 34, "left": 280}, "words": "非甾体抗炎药物( NSAIDS)包括选择性环氧合酶2(COX-2抑制剂)可"}, {"probability": {"variance": 4e-06, "average": 0.999037, "min": 0.99066}, "location": {"width": 807, "top": 764, "height": 33, "left": 235}, "words": "能降低利尿剂和其他抗高血压药的作用,机制尚不明确。因此,本品的抗高血"}, {"probability": {"variance": 0.003964, "average": 0.973344, "min": 0.741266}, "location": {"width": 513, "top": 812, "height": 32, "left": 236}, "words": "压作用可能会被 NSAIDS包括COX-2抑制剂削弱"}, {"probability": {"variance": 3e-06, "average": 0.998692, "min": 0.993057}, "location": {"width": 763, "top": 859, "height": 30, "left": 280}, "words": "麻黄含有麻黄碱和伪麻黄碱,可降低抗高血压药的疗效,使用本品治疗的"}, {"probability": {"variance": 5e-06, "average": 0.998501, "min": 0.991632}, "location": {"width": 386, "top": 906, "height": 29, "left": 235}, "words": "高血压患者应避免使用含麻黄的制剂"}, {"probability": {"variance": 6.3e-05, "average": 0.996894, "min": 0.956281}, "location": {"width": 765, "top": 950, "height": 32, "left": 280}, "words": "依据本品的药代动力学特征以及同类药物氯沙坦钾的临床研究结果,推测"}, {"probability": {"variance": 7.4e-05, "average": 0.996607, "min": 0.959819}, "location": {"width": 809, "top": 996, "height": 32, "left": 235}, "words": "本品与氟康唑、西咪替丁、利福平、苯巴比妥、氢氯噻嗪、地高辛、华法林等"}, {"probability": {"variance": 0, "average": 0.999233, "min": 0.997376}, "location": {"width": 550, "top": 1044, "height": 30, "left": 236}, "words": "不具有临床意义的相互作用,但缺乏相应的研究数据"}, {"probability": {"variance": 1e-06, "average": 0.99919, "min": 0.997867}, "location": {"width": 128, "top": 1107, "height": 29, "left": 242}, "words": "【药物过量】"}, {"probability": {"variance": 0.038701, "average": 0.722039, "min": 0.525312}, "location": {"width": 148, "top": 1109, "height": 28, "left": 956}, "words": "市药"}, {"probability": {"variance": 0.007745, "average": 0.971393, "min": 0.60655}, "location": {"width": 793, "top": 1144, "height": 38, "left": 283}, "words": "尚无过量使用的病例报告。健康受试者单剂口服本品最高达400mg,耐受2"}, {"probability": {"variance": 4e-06, "average": 0.998542, "min": 0.991796}, "location": {"width": 805, "top": 1197, "height": 32, "left": 236}, "words": "性良好。用药过量最可能的表现将是低血压和心动过速。由于副交感神经(迷"}, {"probability": {"variance": 5e-06, "average": 0.998672, "min": 0.9882}, "location": {"width": 809, "top": 1245, "height": 30, "left": 235}, "words": "走神经)的兴奋,可发生心动过缓。如果发生症状性低血压,应该给予支持疗"}, {"probability": {"variance": 0, "average": 0.99962, "min": 0.99962}, "location": {"width": 30, "top": 1294, "height": 28, "left": 236}, "words": "法"}, {"probability": {"variance": 2.1e-05, "average": 0.998272, "min": 0.978487}, "location": {"width": 469, "top": 1338, "height": 29, "left": 282}, "words": "本品的活性代谢产物不能通过血液透析而清除"}, {"probability": {"variance": 4.7e-05, "average": 0.993393, "min": 0.983168}, "location": {"width": 128, "top": 1402, "height": 30, "left": 243}, "words": "【临床试验】"}, {"probability": {"variance": 2e-06, "average": 0.999349, "min": 0.992406}, "location": {"width": 763, "top": 1447, "height": 32, "left": 282}, "words": "本品抗高血压的疗效已经在3个对照研究中得到证明。其中共有690名患"}, {"probability": {"variance": 1.1e-05, "average": 0.997802, "min": 0.981762}, "location": {"width": 797, "top": 1495, "height": 30, "left": 237}, "words": "者服用本品,138名患者服用安慰剂,407名患者服用阳性对照药物氯沙坦钾"}, {"probability": {"variance": 0.000119, "average": 0.977677, "min": 0.96676}, "location": {"width": 18, "top": 1571, "height": 19, "left": 656}, "words": "11"}], "language": 3}